Previous Article | Next Article ![]()
Infection and Immunity, March 2000, p. 1731-1734, Vol. 68, No. 3
Novavax, Rockville,
Maryland,1 and Department of Biological
Sciences,2 The Biofilm Research
Group,3 and Department of Microbiology
and Infectious Diseases,4 University of
Calgary, Calgary, Alberta, Canada
Received 12 October 1999/Accepted 30 November 1999
Bacterial lipopolysaccharide (LPS) is an important agent of
induction of ocular pathology following corneal injury or wearing of
contaminated contact lenses. The mechanism of LPS uptake through the
corneal epithelium is unclear, and the role played by inflammatory cells in this phenomenon has not been previously assessed. Fluorescein isothiocyanate-labeled LPS from Escherichia coli was
deposited onto the abraded corneas of New Zealand White rabbits.
Epifluorescence microscopy of living excised corneas revealed diffuse
LPS staining in the epithelial and stromal layers only in the vicinity
of the abrasion. In addition, specific cellular uptake of LPS was
suggested by fluorescence staining of cells along the abrasion site. In a second series of experiments, an anti-CD18 polyclonal antibody was
used to block infiltration of polymorphonuclear neutrophils (PMN) into
the cornea. In these experiments, a diffuse distribution of fluorescent
LPS was still observed along the abrasion, but the specific cellular
uptake was abolished. The findings indicate that LPS enters the cornea
via diffuse penetration at sites of injury and that specific cellular
uptake of LPS occurs within the cornea via PMN which have
migrated into the damaged tissue.
Complications of common ocular
diseases such as conjunctivitis, keratitis, ulceration, and
general inflammation may result in impaired visual function
(1-3). Although bacterial colonization of the eye clearly
contributes to the pathogenesis of eye disease, these disorders may
also result in the absence of culturable bacteria (1), and
at least in part because of host defense factors. Such disorders may be
associated with contact lens wear (1-3, 6, 7, 11, 13) or
with specific surgical procedures (S. P. Holland, R. Mathias,
D. W. Morck, and S. Slade, submitted for publication). Indeed,
overwhelming infiltration by polymorphonuclear neutrophils (PMN) is
known to play a central role in the pathogenesis of tissue damage at
numerous sites, including the eye (10). Yet, the role played
by these host cells in the pathogenesis of ocular disease remains
unclear. Also, while lipopolysaccharide (LPS) has been shown to induce
corneal damage (10), the route of entry of free LPS into the
corneal tissue has yet to be clarified.
Bacterial LPS (endotoxin) can induce a variety of symptoms, including
fever, reduction of blood pressure, inflammation, and tissue ulceration
(8). LPS activates complement and initiates the production
of numerous cytokines (8, 9). Activation of these various
responses, either individually or concurrently, may cause systemic
and/or localized pathology (8). Indeed, induction of the
complement system may lead to the production of anaphylatoxins (C3a and
C5a) and cytokines such as interleukin-1, tumor necrosis factor alpha,
and interleukin-2, which are potent proinflammatory mediators (8,
9, 14). These, in turn, amplify PMN recruitment at the sites of
inflammation, hence contributing to the perpetuation of tissue injury
(10). The objective of these experiments was to characterize
the mechanisms of uptake of bacterial LPS at sites of
corneal injury and to assess the role played by PMN in this phenomenon.
Adult New Zealand White rabbits (1.5 to 2.5 kg) were housed at the
University of Calgary Life and Environmental Animal Resource Centre and
provided commercial rabbit chow and water ad libitum. All animal
procedures were carried out according to the guidelines of the Canadian
Council of Animal Care and followed procedures approved by the
University of Calgary Animal Care Ethics Committee. Rabbits were
anesthetized with halothane (4%; 2 liters per min). Corneas were
abraded over an approximate length of 1 cm with a sterile 26-gauge
needle from the medial canthus to the lateral canthus, with care being
taken to limit the depth of abrasion of the epithelial layer, as
described previously (4, 10). Following the abrasion, 10 µl of fluorescein isothiocyanate (FITC)-conjugated LPS (1 mg/ml; from
Escherichia coli O55:B5 (List Biological Labs Inc.,
Campbell, Calif.) was applied to the corneal surface with a 10-µl
Hamilton syringe. At 15 min postinoculation, the animals were
euthanized with an overdose of sodium pentabarbital. Corneas were
removed, rinsed in sterile phosphate-buffered saline (PBS), resuspended
in sterile PBS, placed in 24-well sterile tissue culture plates (Nunc),
and incubated at 37°C (5% CO2) until being observed with
an epifluorescence microscope, approximately 30 min postsurgery. IB4
antibody, a polyclonal antibody raised in rabbits against the PMN CD18
surface antigen, was a gift from John Wallace at the University of
Calgary. This antibody is known to block CD18-dependent neutrophil
extravasation (14). The antibody was delivered intravenously at a concentration of 1 mg of protein per kg of body weight in a 1-ml
volume of sterile PBS, 18.25 h prior to surgery. One group of rabbits
served as controls (n = 6 eyes); a second group was treated with IB4 (n = 6 eyes). In each animal, one eye
was abraded while the contralateral side remained unmanipulated.
Excised corneal preparations were observed with an inverted
epifluorescence microscope (Zeiss Axiovert 25). The entire corneal
surfaces were assessed for LPS staining. Observations were recorded
with a Nikon 35-mm camera on 200-ASA Kodachrome film. Cells labeled
with FITC-LPS were counted by using the 10× magnification lens. Cell
counts were expressed as the mean number of cells per field of view
under the 10× lens ± the standard error of the mean.
Values were compared by one-way analysis of variance and the Student
Newman-Keuls test for multiple comparisons. P values <0.05
were considered significant.
Results from microscopic observations are illustrated in Fig.
1 and 2.
Diffuse fluorescence was detected along the line of abrasion for all
preparations, but not in intact areas of the corneal surface. In
addition, within control animals not exposed to IB4, specific cells
labeled with fluorescent LPS were detected (Fig. 1). No staining was
seen in nonabraded corneal areas (data not shown). Intravenous IB4
treatment abolished cell-specific FITC-LPS staining but did not alter
the diffuse staining along the abrasion line (Fig. 2). As was observed
in controls, FITC-LPS staining was restricted to abrasion sites. In all
animals, no staining was detected on the nonabraded contralateral
eye exposed to FITC-LPS and no specific uptake of FITC-LPS by cells
could be detected (data not shown). Cell counts were performed to
determine the number of cells specifically taking up FITC-LPS per field of view. The results of these FITC-LPS-labeled cell counts are illustrated in Fig. 3. IB4
treatment abolished cell-specific FITC-LPS labeling.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Lipopolysaccharide Entry in the Damaged Cornea and
Specific Uptake by Polymorphonuclear Neutrophils
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (145K):
[in a new window]
FIG. 1.
A photomicrograph of an abraded rabbit cornea that was
exposed to FITC-LPS immediately following abrasion. Note the diffuse
staining of the corneal stroma adjacent to the abrasion and the
concentration of fluorescence staining by cells within the corneal
stroma or on the surface of the cornea. Magnification, ×1,000.

View larger version (136K):
[in a new window]
FIG. 2.
A photomicrograph of an IB4 antibody-exposed, abraded
rabbit cornea that was exposed to FITC-LPS immediately following
abrasion. Note the diffuse staining along the corneal abrasion and the
complete lack of specific cellular uptake of the FITC-LPS.
Magnification, ×1,000.

View larger version (47K):
[in a new window]
FIG. 3.
Cell counts from the abraded corneas of untreated
FITC-LPS-exposed animals (Control) and the abraded corneas of IB4
antibody-treated, FITC-LPS-exposed animals. *, value is significantly
lower than that of control (P < 0.05).
In summary, in an attempt to characterize the mechanism of uptake of bacterial LPS into corneal tissue, this study investigated the effects of FITC-conjugated LPS deposition onto rabbit corneas, in the presence or in the absence of epithelial abrasion. The findings indicate that LPS enters the cornea only at sites of injury and that the uptake occurs via two distinct mechanisms: (i) via passive diffusion into the injured epithelium, and (ii) via specific cellular uptake. These results are consistent with the intact corneal epithelium acting as a barrier against entry of proinflammatory soluble products. Using a CD18 antibody clearly assisted in the identification of the cells responsible for FITC-LPS uptake as PMN. These findings confirm the observations of other investigators who demonstrated that the PMN is the primary immune cell type infiltrating corneal surfaces early in inflammation of the eye (4, 10). Data presented here add to these observations evidence that the PMN acts as the sequestration cell for LPS that has entered into the cornea. PMN are responsible for the development of corneal marginal infiltrates and are a well-established feature of the pathologic changes seen in diffuse lamellar keratitis (5, 12; S. P. Holland, R. Mathias, D. W. Morck, and S. Slade, submitted for publication) (Sands of the Sahara keratitis) following laser-assisted in situ keratomileusis. Corneal marginal infiltrates are known to occur as a result of direct bacterial infection or following contact of the ocular surface with contaminated medical devices, including contact lenses (7, 16, 17), and Sands of the Sahara keratitis (5, 12; S. P. Holland, R. Mathias, D. W. Morck, and S. Slade, submitted for publication) is suspected to be caused by LPS contamination of laser surgery sites. Findings from the present study demonstrate that LPS alone may recruit PMN at sites of epithelial injury and hence may contribute to these syndromes. Since unchecked PMN infiltration is directly responsible for tissue pathology in a number of inflammatory diseases (15), this study further underscores the significance of LPS contamination as a possible contributor to specific ocular diseases. Experiments described herein lay the basis for future research into the basic mechanisms by which host defense factors may contribute to the pathogenesis of such diseases.
| |
ACKNOWLEDGMENTS |
|---|
This study was funded by The Natural Sciences and Engineering Research Council of Canada.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: University of Calgary, 2500 University Dr. NW, Calgary, Alberta, Canada T2N 1N4. Phone: (403) 220-5278. Fax: (403) 284-1537. E-mail: dmorck{at}ucalgary.ca.
Editor: J. D. Clements
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bates, A. K., R. J. Morris, and F. Stapleton. 1989. Sterile infiltrates and contact lens wearers. Eye 3:803-806. |
| 2. | Crook, T. 1985. Corneal infiltrates with red eye related to duration of extended wear. J. Am. Optom. Assoc. 56:698-700[Medline]. |
| 3. | Dunn, J. P., B. J. Mondino, B. A. Weisman, and J. A. Bruckner. 1989. Corneal ulcers associated with disposable hydrogel contact lenses. Am. J. Ophthalmol. 108:113-117[Medline]. |
| 4. | Elliott, E., Z. Li, C. Bell, D. Stiel, A. Buret, T. Wallace, I. Brzuszczak, and E. O'Loughlin. 1994. Modulation of host response to Escherichia coli O157:H7 infection by anti-CD18 antibody in rabbits. Gastroenterology 106:1554-1561[Medline]. |
| 5. | Holland, S. P. 1999. Update in cornea and external disease: solving the mystery of "sands of the Sahara" syndrome (diffuse lamellar keratitis). Can. J. Ophthalmol. 34:93-94[Medline]. |
| 6. | Josephson, J. E., and B. E. Caffery. 1979. Infiltrative keratitis in hydrogel lens wearers. ICLC 6:47-70. |
| 7. | Lawin-Brussel, C. A., M. F. Refojo, F. L. Leong, and K. R. Kenyon. 1993. Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea 12:10-18[Medline]. |
| 8. | Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417-432[Medline]. |
| 9. | Nowotny, A. 1983. In search of the active site in endotoxins, p. 22-31. In A. Nowotny (ed.), Beneficial effects of endotoxins. Plenum Press, New York, N.Y. |
| 10. | Schultz, C. L., D. W. Morck, S. G. McKay, M. E. Olson, and A. Buret. 1997. Lipopolysaccharide induced acute red eye and corneal ulcers. Exp. Eye Res. 64:3-9[CrossRef][Medline]. |
| 11. | Silbert, J. T. 1988. Microbial disease and the contact lens patient. ICLC 15:221-229. |
| 12. | Smith, R. J., and R. K. Maloney. 1998. Diffuse lamellar keratitis: a new syndrome in lamellar refractive surgery. Ophthalmology 105:1721-1726[CrossRef][Medline]. |
| 13. | Stein, R. N. M., T. E. Clinch, E. J. Cohen, G. I. Genvert, J. J. Arentsen, and P. R. Laibson. 1988. Infected vs. sterile corneal infiltrates in contact lens wearers. Am. J. Ophthalmol. 105:632-663[Medline]. |
| 14. | Tesh, V. L., and D. C. Morrison. 1988. The interaction of Escherichia coli with normal human serum: factors affecting the capacity of serum to mediate lipopolysaccharide release. Microb. Pathog. 4:175-187[CrossRef][Medline]. |
| 15. | Thygeson, P. 1947. Marginal corneal infiltrates and ulcers. Trans. Am. Acad. Ophthalmol. Otolaryngol. January/February:198-209. |
| 16. | Zantos, S. G. 1984. Corneal infiltrates, debris and microcysts. J. Am. Optom. Assoc. 55:196-198. |
| 17. | Zantos, S. G. 1984. Management of corneal infiltrates in extended-wear contact lens patients. ICLC 11:604-612. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»